Insider Trading Alert - FLT, WLL, WST, ACT And HAL Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 7, 2013, 132 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $555.62 to $810,125,000.00.

Highlighted Stocks Traded by Insiders:

Fleetcor Technologies (FLT) - FREE Research Report

Buckman Michael who is Director at Fleetcor Technologies bought 5,000 shares at $116.68 on Nov. 7, 2013. Following this transaction, the Director owned 6,500 shares meaning that the stake was reduced by 333.33% with the 5,000 share transaction.

The shares most recently traded at $112.98, down $3.70, or 3.28% since the insider transaction. Historical insider transactions for Fleetcor Technologies go as follows:

  • 12-Week # shares sold: 2.8 million
  • 24-Week # shares sold: 2.8 million

The average volume for Fleetcor Technologies has been 753,900 shares per day over the past 30 days. Fleetcor Technologies has a market cap of $9.4 billion and is part of the services sector and diversified services industry. Shares are up 113.81% year to date as of the close of trading on Thursday.

FleetCor Technologies, Inc. provides fuel cards and workforce payment products and services to businesses, commercial fleets, oil companies, petroleum marketers, and government entities in North America, Latin America, and Europe. The company has a P/E ratio of 34.4. Currently there are 3 analysts that rate Fleetcor Technologies a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FLT - FREE

TheStreet Quant Ratings rates Fleetcor Technologies as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Fleetcor Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Whiting Petroleum Corporation (WLL) - FREE Research Report

Volker James J who is Chairman and CEO at Whiting Petroleum Corporation bought 1,000 shares at $64.84 on Nov. 7, 2013. Following this transaction, the Chairman and CEO owned 110,731 shares meaning that the stake was reduced by 0.91% with the 1,000 share transaction.

The shares most recently traded at $63.18, down $1.66, or 2.62% since the insider transaction. Historical insider transactions for Whiting Petroleum Corporation go as follows:

  • 4-Week # shares sold: 70,908
  • 12-Week # shares sold: 70,908
  • 24-Week # shares sold: 70,908

The average volume for Whiting Petroleum Corporation has been 2.1 million shares per day over the past 30 days. Whiting Petroleum Corporation has a market cap of $7.7 billion and is part of the basic materials sector and energy industry. Shares are up 49.99% year to date as of the close of trading on Thursday.

Whiting Petroleum Corporation, an independent oil and gas company, engages in the acquisition, exploration, exploitation, development, and production of crude oil, natural gas liquids, and natural gas in the United States. The company has a P/E ratio of 15.3. Currently there are 19 analysts that rate Whiting Petroleum Corporation a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WLL - FREE

TheStreet Quant Ratings rates Whiting Petroleum Corporation as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, expanding profit margins, good cash flow from operations and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Whiting Petroleum Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

West Pharmaceutical Services (WST) - FREE Research Report

Anderson Michael A who is Vice President & Treasurer at West Pharmaceutical Services sold 6,000 shares at $46.53 on Nov. 7, 2013. Following this transaction, the Vice President & Treasurer owned 82,606 shares meaning that the stake was reduced by 6.77% with the 6,000 share transaction.

The shares most recently traded at $46.46, down $0.07, or 0.16% since the insider transaction. Historical insider transactions for West Pharmaceutical Services go as follows:

  • 12-Week # shares sold: 11,883
  • 24-Week # shares sold: 16,583

The average volume for West Pharmaceutical Services has been 251,000 shares per day over the past 30 days. West Pharmaceutical Services has a market cap of $3.3 billion and is part of the health care sector and health services industry. Shares are up 70.12% year to date as of the close of trading on Thursday.

West Pharmaceutical Services, Inc. manufactures and sells components and systems for injectable drug delivery and plastic packaging, as well as delivery system components for the pharmaceutical, healthcare, and consumer products industries. The stock currently has a dividend yield of 0.86%. The company has a P/E ratio of 30.0. Currently there is 1 analyst that rates West Pharmaceutical Services a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WST - FREE

TheStreet Quant Ratings rates West Pharmaceutical Services as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, compelling growth in net income, expanding profit margins and solid stock price performance. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full West Pharmaceutical Services Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Actavis (ACT) - FREE Research Report

Joyce R Todd who is CFO-Global at Actavis sold 22,500 shares at $157.48 on Nov. 7, 2013. Following this transaction, the CFO-Global owned 54,600 shares meaning that the stake was reduced by 29.18% with the 22,500 share transaction.

The shares most recently traded at $145.10, down $12.38, or 8.53% since the insider transaction. Historical insider transactions for Actavis go as follows:

  • 12-Week # shares sold: 119,013
  • 24-Week # shares sold: 145,976

The average volume for Actavis has been 1.1 million shares per day over the past 30 days. Actavis has a market cap of $18.6 billion and is part of the health care sector and drugs industry. Shares are up 62.01% year to date as of the close of trading on Monday.

Actavis plc, an integrated specialty pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical products in the United States, Canada, and internationally.

Exclusive Offer: Get the latest Stock Analysis on ACT - FREE

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Halliburton Company (HAL) - FREE Research Report

Rainey Joe D who is Pres., Eastern Hemisphere at Halliburton Company sold 10,546 shares at $54.45 on Nov. 7, 2013. Following this transaction, the Pres., Eastern Hemisphere owned 179,402 shares meaning that the stake was reduced by 5.55% with the 10,546 share transaction.

The shares most recently traded at $54.53, up $0.08, or 0.15% since the insider transaction. Historical insider transactions for Halliburton Company go as follows:

  • 4-Week # shares sold: 25,388
  • 12-Week # shares sold: 133,610
  • 24-Week # shares sold: 187,632

The average volume for Halliburton Company has been 9.2 million shares per day over the past 30 days. Halliburton Company has a market cap of $46.1 billion and is part of the basic materials sector and energy industry. Shares are up 56.82% year to date as of the close of trading on Thursday.

Halliburton Company provides a range of services and products for the exploration, development, and production of oil and natural gas to oil and gas companies worldwide. The company operates in two segments, Completion and Production, and Drilling and Evaluation. The stock currently has a dividend yield of 1.1%. The company has a P/E ratio of 26.0. Currently there are 18 analysts that rate Halliburton Company a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HAL - FREE

TheStreet Quant Ratings rates Halliburton Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Halliburton Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%